Bio-Rad Laboratories (BIO) Interest Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Interest Expenses data on file, last reported at $33.2 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 49.55% year-over-year to $33.2 million in Q1 2026; TTM through Mar 2026 was $33.2 million, a 33.47% decrease from a year earlier, with the FY2025 full-year figure at $79.8 million, down 16.18% from the prior year.
• Interest Expenses for Q1 2026 stood at $33.2 million, up from $12.1 million in the prior quarter.
• Over the last five years, Interest Expenses for BIO reached as high as $37.3 million in Q2 2025 and fell as low as $3.3 million in Q4 2024.
• Historically, Interest Expenses has averaged $15.9 million across 5 years, with a median of $12.3 million in 2024.
• Across the five-year window, Interest Expenses surged 2637.79% in 2022 and sank 73.22% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $11.7 million in 2022, then gained by 5.6% to $12.3 million in 2023, then sank by 73.22% to $3.3 million in 2024, then jumped by 266.67% to $12.1 million in 2025, then soared by 174.38% to $33.2 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $33.2 million in Q1 2026, $12.1 million in Q4 2025, and $12.3 million in Q3 2025.